Show simple item record

dc.contributor.authorAylwin, S
dc.contributor.authorBurst, V
dc.contributor.authorPeri, A
dc.contributor.authorRunkle, I
dc.contributor.authorThatcher, Nick
dc.date.accessioned2015-12-10T09:39:50Zen
dc.date.available2015-12-10T09:39:50Zen
dc.date.issued2015en
dc.identifier.citation'Dos and don'ts' in the management of hyponatremia. 2015, 31 (9):1755-61 Curr Med Res Opinen
dc.identifier.issn1473-4877en
dc.identifier.pmid26173050en
dc.identifier.doi10.1185/03007995.2015.1072706en
dc.identifier.urihttp://hdl.handle.net/10541/583544en
dc.description.abstractThe management of hyponatremia has evolved in recent years, particularly with the introduction of tolvaptan for hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion (SIADH). This commentary presents a summary of recent international recommendations in the form of a series of didactic 'dos and don'ts', in order to provide concise, practical guidance for practising clinicians focused on the investigation and management of euvolemic hyponatremia (SIADH).
dc.language.isoenen
dc.rightsArchived with thanks to Current medical research and opinionen
dc.title'Dos and don'ts' in the management of hyponatremia.en
dc.typeArticleen
dc.contributor.departmentDepartment of Endocrinology , King's College Hospital Londonen
dc.identifier.journalCurrent Medical Research and Opinionen
html.description.abstractThe management of hyponatremia has evolved in recent years, particularly with the introduction of tolvaptan for hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion (SIADH). This commentary presents a summary of recent international recommendations in the form of a series of didactic 'dos and don'ts', in order to provide concise, practical guidance for practising clinicians focused on the investigation and management of euvolemic hyponatremia (SIADH).


This item appears in the following Collection(s)

Show simple item record